• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球分析德尔塔和奥密克戎变异株流行期间 COVID-19 感染病死率及其相关因素:一项生态学研究。

A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study.

机构信息

School of Health Care Administration, College of Management, Taipei Medical University, Taipei, Taiwan.

Health Personnel Training Institute, University of Medicine and Pharmacy, Hue University, Hue, Vietnam.

出版信息

Front Public Health. 2023 Jun 2;11:1145138. doi: 10.3389/fpubh.2023.1145138. eCollection 2023.

DOI:10.3389/fpubh.2023.1145138
PMID:37333556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10274323/
Abstract

BACKGROUND

The Omicron variant of SARS-CoV-2 is more highly infectious and transmissible than prior variants of concern. It was unclear which factors might have contributed to the alteration of COVID-19 cases and deaths during the Delta and Omicron variant periods. This study aimed to compare the COVID-19 average weekly infection fatality rate (AWIFR), investigate factors associated with COVID-19 AWIFR, and explore the factors linked to the increase in COVID-19 AWIFR between two periods of Delta and Omicron variants.

MATERIALS AND METHODS

An ecological study has been conducted among 110 countries over the first 12 weeks during two periods of Delta and Omicron variant dominance using open publicly available datasets. Our analysis included 102 countries in the Delta period and 107 countries in the Omicron period. Linear mixed-effects models and linear regression models were used to explore factors associated with the variation of AWIFR over Delta and Omicron periods.

FINDINGS

During the Delta period, the lower AWIFR was witnessed in countries with better government effectiveness index [β = -0.762, 95% CI (-1.238)-(-0.287)] and higher proportion of the people fully vaccinated [β = -0.385, 95% CI (-0.629)-(-0.141)]. In contrast, a higher burden of cardiovascular diseases was positively associated with AWIFR (β = 0.517, 95% CI 0.102-0.932). Over the Omicron period, while years lived with disability (YLD) caused by metabolism disorders (β = 0.843, 95% CI 0.486-1.2), the proportion of the population aged older than 65 years (β = 0.737, 95% CI 0.237-1.238) was positively associated with poorer AWIFR, and the high proportion of the population vaccinated with a booster dose [β = -0.321, 95% CI (-0.624)-(-0.018)] was linked with the better outcome. Over two periods of Delta and Omicron, the increase in government effectiveness index was associated with a decrease in AWIFR [β = -0.438, 95% CI (-0.750)-(-0.126)]; whereas, higher death rates caused by diabetes and kidney (β = 0.472, 95% CI 0.089-0.855) and percentage of population aged older than 65 years (β = 0.407, 95% CI 0.013-0.802) were associated with a significant increase in AWIFR.

CONCLUSION

The COVID-19 infection fatality rates were strongly linked with the coverage of vaccination rate, effectiveness of government, and health burden related to chronic diseases. Therefore, proper policies for the improvement of vaccination coverage and support of vulnerable groups could substantially mitigate the burden of COVID-19.

摘要

背景

SARS-CoV-2 的奥密克戎变体比之前的关切变体更具传染性和传播性。尚不清楚哪些因素可能导致德尔塔和奥密克戎变体期间 COVID-19 病例和死亡人数的变化。本研究旨在比较 COVID-19 平均每周感染病死率(AWIFR),探讨与 COVID-19 AWIFR 相关的因素,并探讨在德尔塔和奥密克戎变体两个时期之间导致 COVID-19 AWIFR 增加的因素。

材料和方法

在德尔塔和奥密克戎变体主导的前 12 周内,使用公开的可获得数据集,对 110 个国家进行了生态研究。我们的分析包括德尔塔时期的 102 个国家和奥密克戎时期的 107 个国家。线性混合效应模型和线性回归模型用于探索与德尔塔和奥密克戎时期 AWIFR 变化相关的因素。

结果

在德尔塔时期,政府效能指数较好的国家的 AWIFR 较低[β=-0.762,95%CI(-1.238)-(-0.287)],完全接种疫苗的人口比例较高的国家的 AWIFR 较低[β=-0.385,95%CI(-0.629)-(-0.141)]。相比之下,心血管疾病负担较高与 AWIFR 呈正相关(β=0.517,95%CI 0.102-0.932)。在奥密克戎时期,虽然由代谢紊乱引起的伤残年数(YLD)(β=0.843,95%CI 0.486-1.2)和 65 岁以上人口比例(β=0.737,95%CI 0.237-1.238)与较差的 AWIFR 呈正相关,但高比例的人群接种加强针[β=-0.321,95%CI(-0.624)-(-0.018)]与更好的结果相关。在德尔塔和奥密克戎两个时期,政府效能指数的提高与 AWIFR 的降低有关[β=-0.438,95%CI(-0.750)-(-0.126)];而糖尿病和肾脏导致的死亡率较高(β=0.472,95%CI 0.089-0.855)和 65 岁以上人口比例较高(β=0.407,95%CI 0.013-0.802)与 AWIFR 的显著增加有关。

结论

COVID-19 感染病死率与疫苗接种率、政府效能和与慢性病相关的健康负担密切相关。因此,改善疫苗接种覆盖率和支持弱势群体的适当政策可以显著减轻 COVID-19 的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/d93cf7a2db6c/fpubh-11-1145138-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/c083237eb780/fpubh-11-1145138-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/59a493117794/fpubh-11-1145138-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/c0e1b522be75/fpubh-11-1145138-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/daeecfb3a616/fpubh-11-1145138-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/937c8dd539d5/fpubh-11-1145138-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/8a8afddcc2bb/fpubh-11-1145138-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/14beecac8dc3/fpubh-11-1145138-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/d93cf7a2db6c/fpubh-11-1145138-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/c083237eb780/fpubh-11-1145138-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/59a493117794/fpubh-11-1145138-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/c0e1b522be75/fpubh-11-1145138-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/daeecfb3a616/fpubh-11-1145138-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/937c8dd539d5/fpubh-11-1145138-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/8a8afddcc2bb/fpubh-11-1145138-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/14beecac8dc3/fpubh-11-1145138-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0299/10274323/d93cf7a2db6c/fpubh-11-1145138-g0008.jpg

相似文献

1
A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study.全球分析德尔塔和奥密克戎变异株流行期间 COVID-19 感染病死率及其相关因素:一项生态学研究。
Front Public Health. 2023 Jun 2;11:1145138. doi: 10.3389/fpubh.2023.1145138. eCollection 2023.
2
Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods.Delta和Omicron变异株流行期间29个国家新冠病毒恢复力指数及其相关因素的比较
Vaccines (Basel). 2022 Jun 13;10(6):940. doi: 10.3390/vaccines10060940.
3
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
4
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
5
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性:一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
6
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.奥密克戎变异株的流行和抗 SARS-CoV-2 疫苗接种是系统性自身免疫性风湿病患者 COVID-19 轻症化的关键决定因素。
Clin Rheumatol. 2023 Dec;42(12):3375-3385. doi: 10.1007/s10067-023-06769-4. Epub 2023 Sep 21.
7
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国,2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
8
Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.SARS-CoV-2 的 Alpha、Delta 和奥密克戎变异株的替代动力学和发病机制。
Epidemiol Infect. 2022 Dec 20;151:e32. doi: 10.1017/S0950268822001935.
9
Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.奥密克戎变异株与德尔塔变异株相关的 COVID-19 发病率和病死率的差异与疫苗覆盖率有关:一项全球性综述。
J Med Virol. 2023 Jan;95(1):e28118. doi: 10.1002/jmv.28118. Epub 2022 Sep 20.
10
Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.估计 BNT162b2 疫苗对美国 5 至 11 岁儿童感染德尔塔和奥密克戎变异株的有效性。
JAMA Netw Open. 2022 Dec 1;5(12):e2246915. doi: 10.1001/jamanetworkopen.2022.46915.

引用本文的文献

1
Octreotide and direct/indirect lung injury.奥曲肽与直接/间接肺损伤。
Res Pharm Sci. 2025 Aug 25;20(4):469-484. doi: 10.4103/RPS.RPS_67_24. eCollection 2025 Aug.
2
Association of COPD With Clinical Outcomes After Hospital Admission in SARS-CoV-2 Patients During the Omicron Variant Period: A Retrospective Cohort Study.奥密克戎变异株流行期间,SARS-CoV-2感染患者住院后慢性阻塞性肺疾病与临床结局的关联:一项回顾性队列研究
Clin Respir J. 2025 Jul;19(7):e70104. doi: 10.1111/crj.70104.
3
Antibody levels versus vaccination status in the outcome of older adults with COVID-19.

本文引用的文献

1
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom.英国布里斯托尔住院成人中奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)新冠病毒感染的严重程度:一项前瞻性队列研究
Lancet Reg Health Eur. 2023 Feb;25:100556. doi: 10.1016/j.lanepe.2022.100556. Epub 2022 Dec 12.
2
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.SARS-CoV-2 奥密克戎是一种具有改变的细胞进入途径的免疫逃逸变体。
Nat Microbiol. 2022 Aug;7(8):1161-1179. doi: 10.1038/s41564-022-01143-7. Epub 2022 Jul 7.
3
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
抗体水平与 COVID-19 老年患者结局的疫苗接种状态。
JCI Insight. 2024 Oct 22;9(20):e183913. doi: 10.1172/jci.insight.183913.
4
Country-specific determinants for COVID-19 case fatality rate and response strategies from a global perspective: an interpretable machine learning framework.从全球视角看 COVID-19 病死率的国家特有决定因素和应对策略:一个可解释的机器学习框架。
Popul Health Metr. 2024 Jun 3;22(1):10. doi: 10.1186/s12963-024-00330-4.
5
Effectiveness of early pharmaceutical interventions in symptomatic COVID-19 patients: A randomized clinical trial.早期药物干预对有症状的COVID-19患者的有效性:一项随机临床试验。
Pak J Med Sci. 2024 May-Jun;40(5):800-810. doi: 10.12669/pjms.40.5.8757.
6
Estimation of standardized real-time fatality rate for ongoing epidemics.估算正在进行的传染病的标准化实时病死率。
PLoS One. 2024 May 21;19(5):e0303861. doi: 10.1371/journal.pone.0303861. eCollection 2024.
7
COVID-19 vaccine acceptance and its association with knowledge and attitude among patients with chronic diseases in Ethiopia.埃塞俄比亚慢性病患者对 COVID-19 疫苗的接受程度及其与知识和态度的关系。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2350815. doi: 10.1080/21645515.2024.2350815. Epub 2024 May 17.
8
Comparative Analysis of COVID-19 Outcomes in Type 1 and Type 2 Diabetes: A Three-Year Retrospective Study.1 型和 2 型糖尿病患者 COVID-19 结局的对比分析:一项为期三年的回顾性研究。
Medicina (Kaunas). 2024 Jan 25;60(2):210. doi: 10.3390/medicina60020210.
9
Anti-SARS-CoV-2 Antibody Testing: Role and Indications.抗SARS-CoV-2抗体检测:作用与指征
J Clin Med. 2023 Dec 8;12(24):7575. doi: 10.3390/jcm12247575.
10
Analyzing the emerging patterns of SARS-CoV-2 Omicron subvariants for the development of next-gen vaccine: An observational study.分析严重急性呼吸综合征冠状病毒2型奥密克戎亚变体的新出现模式以开发下一代疫苗:一项观察性研究。
Health Sci Rep. 2023 Oct 18;6(10):e1596. doi: 10.1002/hsr2.1596. eCollection 2023 Oct.
奥密克戎变异株比德尔塔变异株更致命且更具传染性吗?
Int J Environ Res Public Health. 2022 Apr 11;19(8):4586. doi: 10.3390/ijerph19084586.
4
The association of intensity and duration of non-pharmacological interventions and implementation of vaccination with COVID-19 infection, death, and excess mortality: Natural experiment in 22 European countries.非药物干预的强度和持续时间以及疫苗接种的实施与 COVID-19 感染、死亡和超额死亡的关联:22 个欧洲国家的自然实验。
J Infect Public Health. 2022 May;15(5):499-507. doi: 10.1016/j.jiph.2022.03.011. Epub 2022 Mar 24.
5
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.奥密克戎和德尔塔变异株主导期间感染新型冠状病毒(SARS-CoV-2)个体的症状流行率、持续时间及住院风险:来自ZOE COVID研究的一项前瞻性观察性研究
Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7.
6
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.估算2019冠状病毒病大流行造成的超额死亡率:2020 - 2021年与2019冠状病毒病相关死亡率的系统分析
Lancet. 2022 Apr 16;399(10334):1513-1536. doi: 10.1016/S0140-6736(21)02796-3. Epub 2022 Mar 10.
7
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.mRNA 疫苗加强剂对卡塔尔奥密克戎感染的保护效果。
N Engl J Med. 2022 May 12;386(19):1804-1816. doi: 10.1056/NEJMoa2200797. Epub 2022 Mar 9.
8
Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.在疫苗接种前时代,按年龄、时间和地理位置划分的 COVID-19 感染病死率变化:系统分析。
Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140-6736(21)02867-1. Epub 2022 Feb 24.
9
Effects of vaccination and non-pharmaceutical interventions and their lag times on the COVID-19 pandemic: Comparison of eight countries.疫苗接种和非药物干预措施及其时滞对 COVID-19 大流行的影响:八个国家的比较。
PLoS Negl Trop Dis. 2022 Jan 13;16(1):e0010101. doi: 10.1371/journal.pntd.0010101. eCollection 2022 Jan.
10
Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show.新冠疫情:南非数据显示,奥密克戎毒株导致的感染病例增多,但住院人数少于德尔塔毒株。
BMJ. 2021 Dec 16;375:n3104. doi: 10.1136/bmj.n3104.